Prot #KO-MEN-007: Phase 1 Study of Venetoclax/Azacitidine or Venetoclax in Combination with Ziftomenib (KO-539) or Standard Induction Cytarabine/Daunorubicin (7+3) Chemotherapy in Combination with Ziftomenib for the Treatment of Patients with Acute Myeloi

Project: Research project

Project Details

StatusActive
Effective start/end date3/12/24 → 3/12/27

Funding

  • Quintiles, Inc. (Prot #KO-MEN-007 // Prot #KO-MEN-007)
  • Kura Oncology, Inc. (Prot #KO-MEN-007 // Prot #KO-MEN-007)